Summary.
Tardive dyskinesia (TD) is one of the major side effects of long – term neuroleptic treatment. The pathophysiology of this disabling and commonly irreversible movement disorder is still obscure. The traditional concept of supersensitivity of striatal dopamine receptors as the mechanism involved in the development of TD is not satisfying, and current studies have focused on the role of neuroleptic – induced neuronal toxicity in the development of TD. We performed a series of experiments to gain a better understanding on the mechanisms involved in induction of TD. We have evaluated the direct neurotoxic effect of haloperidol (HP), a widely – used neuroleptic drug, and its three metabolites, in mouse neuronal cultures and in PC-12 cells.
We found that the features of HP-induced cell death were apoptotic rather than necrotic, as indicated by different DNA-staining methods and specific caspases inhibitors. Moreover, cotreatment with antioxidants such as vitamin E and N-acetylcysteine (NAC) significantly protected the cultures. Further studies on the mechanisms underlying HP-induced toxicity may lead to the development of new neuroprotective therapeutic strategies.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received May 10, 1999; accepted September 6, 1999
Rights and permissions
About this article
Cite this article
Galili-Mosberg, R., Gil-Ad, I., Weizman, A. et al. Haloperidol – induced neurotoxicity – possible implications for tardive dyskinesia. J Neural Transm 107, 479–490 (2000). https://doi.org/10.1007/s007020070089
Issue Date:
DOI: https://doi.org/10.1007/s007020070089